September 20th, 2016
•This manuscript describes clinical protocols for two next-generation sequencing panels. One panel interrogates hematologic malignancies while the other panel targets genes commonly mutated in solid tumors. Molecular classification of driver mutations in human malignancies offers valuable prognostic and predictive information.
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved